InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Pimblett Emily. Director active across 2 companies, notably Eliem Therapeutics, Inc.. Cumulatively, 5 reports have been published. Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Pimblett Emily is a declarant with 5 filings in total. In the recent filings held, all dated between 2024-06-21 and 2025-06-20, the most frequent transaction type is option exercise, and the companies mentioned are Climb Bio, Inc. and Eliem Therapeutics, Inc., with the listed roles of SVP, Finance & CAO and CHIEF ACCOUNTING OFFICER.